F. Zerbib

798 total citations
19 papers, 485 citations indexed

About

F. Zerbib is a scholar working on Surgery, Gastroenterology and Epidemiology. According to data from OpenAlex, F. Zerbib has authored 19 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Gastroenterology and 6 papers in Epidemiology. Recurrent topics in F. Zerbib's work include Gastroesophageal reflux and treatments (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Eosinophilic Esophagitis (5 papers). F. Zerbib is often cited by papers focused on Gastroesophageal reflux and treatments (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Eosinophilic Esophagitis (5 papers). F. Zerbib collaborates with scholars based in France, Australia and United Kingdom. F. Zerbib's co-authors include Sabine Roman, François Mion, Maylis Capdepont, Stanislas Bruley des Varannes, J. P. Galmiche, James I. McDonald, Françis Mégraud, H Lamouliatte, Daniel Sifrim and Richard H. Holloway and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

F. Zerbib

19 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Zerbib France 9 390 383 69 49 32 19 485
Nora Thoua United Kingdom 8 188 0.5× 135 0.4× 45 0.7× 14 0.3× 26 0.8× 12 350
Ramazan Öztürk Türkiye 11 365 0.9× 269 0.7× 23 0.3× 4 0.1× 14 0.4× 29 522
Anthony Choi United States 7 189 0.5× 76 0.2× 24 0.3× 26 0.5× 11 0.3× 24 252
K. A. Kelly United States 9 307 0.8× 153 0.4× 88 1.3× 18 0.4× 76 2.4× 15 524
Tomislav Baudoin Croatia 13 195 0.5× 47 0.1× 66 1.0× 18 0.4× 121 3.8× 49 399
Marcelo de Paula Loureiro Brazil 12 301 0.8× 103 0.3× 75 1.1× 1 0.0× 189 5.9× 47 481
R. Finaly Israel 9 218 0.6× 11 0.0× 39 0.6× 2 0.0× 56 1.8× 23 354
Ali Titiz Türkiye 11 206 0.5× 15 0.0× 91 1.3× 10 0.2× 57 1.8× 24 412
Richard Lindley United Kingdom 10 415 1.1× 112 0.3× 44 0.6× 1 0.0× 9 0.3× 23 458
P. Saar Germany 5 54 0.1× 19 0.0× 17 0.2× 4 0.1× 21 0.7× 7 158

Countries citing papers authored by F. Zerbib

Since Specialization
Citations

This map shows the geographic impact of F. Zerbib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Zerbib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Zerbib more than expected).

Fields of papers citing papers by F. Zerbib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Zerbib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Zerbib. The network helps show where F. Zerbib may publish in the future.

Co-authorship network of co-authors of F. Zerbib

This figure shows the co-authorship network connecting the top 25 collaborators of F. Zerbib. A scholar is included among the top collaborators of F. Zerbib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Zerbib. F. Zerbib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zallot, Camille, F. Zerbib, Laurianne Plastaras, et al.. (2022). Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID. Journal of Crohn s and Colitis. 16(12). 1816–1824. 9 indexed citations
2.
Roman, Sabine, Richard H. Holloway, Jutta Keller, et al.. (2016). Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high‐resolution manometry. Neurogastroenterology & Motility. 29(2). 142 indexed citations
3.
Chabrun, Édouard, Marion Marty, & F. Zerbib. (2012). Development of esophageal adenocarcinoma on buried glands following radiofrequency ablation for Barrett's esophagus. Endoscopy. 44(S 02). E392–E392. 10 indexed citations
4.
Zerbib, F. & D Stoll. (2010). Management of laryngopharyngeal reflux: an unmet medical need. Neurogastroenterology & Motility. 22(2). 109–112. 14 indexed citations
5.
Bouchard, D., F. Pigot, A. Castinel, et al.. (2009). P089 - Results from a prospective study combining infliximab, surgery, and methotrexate in severe fistulising ano-perineal Crohn's disease. Journal of Crohn s and Colitis. 3(1). S46–S46. 2 indexed citations
6.
Thibaut, S., Nükhet Cavusoglu, F. Zerbib, et al.. (2008). Transglutaminase-3 Enzyme: A Putative Actor in Human Hair Shaft Scaffolding?. Journal of Investigative Dermatology. 129(2). 449–459. 26 indexed citations
8.
Schaeverbeke, Thierry, Nathalie Broutet, F. Zerbib, et al.. (2005). Should We Eradicate Helicobacter pylori Before Prescribing an NSAID? Result of a Placebo-Controlled Study. The American Journal of Gastroenterology. 100(12). 2637–2643. 5 indexed citations
9.
Zerbib, F., et al.. (2004). SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans. Alimentary Pharmacology & Therapeutics. 19(8). 931–939. 5 indexed citations
10.
Amouretti, M, Pierre Czernichow, Patrick Hochain, et al.. (2000). [Management of upper digestive hemorrhage occurring in the community: patterns of patient care in 4 French administrative areas].. PubMed. 24(11). 1003–11. 14 indexed citations
12.
Collet, D., F. Zerbib, Patrick Ledaguenel, & J Périssat. (1997). [Laparoscopic fundoplication for gastroesophageal reflux. Apropos of our first 123 patients].. PubMed. 51(10). 1084–91. 5 indexed citations
13.
Zerbib, F., et al.. (1996). [Simultaneous study of tones of the lower esophageal sphincter and proximal stomach in healthy humans].. PubMed. 20(12). 1078–83. 6 indexed citations
14.
Lamouliatte, H, et al.. (1996). Triple therapy with PPI-amoxicillin-clarithromycin for H pylori eradication The optimal regimen in 1996. 171. 8 indexed citations
15.
Leray, Véronique, et al.. (1996). [Expression of the gene of cholecystokinin. Demonstration from duodenal biopsies in man].. PubMed. 19(8-9). 659–63. 6 indexed citations
16.
Lamouliatte, H, et al.. (1995). Triple therapy with proton pump inhibitor - amoxicillin and clarithromycin for Helicobacter pylori eradication. Gastroenterology. 108(4). A143–A143. 6 indexed citations
17.
Zerbib, F., et al.. (1994). Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for H pylori eradication Results of a randomized controlled trial among 100 patients. The American Journal of Gastroenterology. 89(8). 1366. 22 indexed citations
18.
Zerbib, F., et al.. (1994). Alosetron does not affect the visceral perception of gastric distension in healthy subjects. Alimentary Pharmacology & Therapeutics. 8(4). 403–407. 52 indexed citations
19.
Béchade, Dominique, et al.. (1993). [Abdominal paraesophageal bronchogenic cyst].. PubMed. 17(10). 758–61. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026